(Q35779335)

10 August 2017

title

The pharmacology of bipolar disorder during pregnancy and breastfeeding (English)

1 reference

10 August 2017

0 references

1 reference

2

1 reference

10 August 2017

Seetal Dodd

1

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

Expert Opinion on Drug Safety

10 August 2017

published in

1 reference

10 August 2017

volume

3

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

221-229

1 reference

Protective effect of pregnancy in women with lithium-responsive bipolar disorder.

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Puerperal mental disorders in manic-depressive females.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Epidemiology of puerperal psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Maternal depression: a child's first adverse life event

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Intellectual problems shown by 11-year-old children whose mothers had postnatal depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Effects of postnatal depression on infant development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

A reevaluation of risk of in utero exposure to lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

The effects of lithium, valproic acid, and carbamazepine during pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Atrial flutter in the newborn resulting from maternal lithium ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Letter: Transplacental lithium poisoning: Reversible inhibition of fetal thyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Nephrogenic diabetes insipidus in transplacental lithium intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Case report and review of the perinatal implications of maternal lithium use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Lithium toxicity in a neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Maternal valproic acid and congenital neural tube defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Spina bifida and in-utero exposure to valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

The fetal valproate syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Verification of the fetal valproate syndrome phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Pattern of malformations in the children of women treated with carbamazepine during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Spina bifida in infants of women treated with carbamazepine during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Recent developments in the treatment of bipolar disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Antiepileptic drug pharmacokinetics during pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Transplacental passage of oxcarbazepine and its metabolites in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Clinical pharmacokinetics of oxcarbazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Olanzapine versus divalproex in the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Olanzapine-exposed pregnancies and lactation: early experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

21 January 2018

Quetiapine and pregnancy

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Assessment and treatment of depression during pregnancy: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Antidepressants and breast-feeding: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

Effects of Maternal Depression on Cognitive Development of Children Over the First 7 Years of Life

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.3.221

21 January 2018

Identifiers

DOI

10.1517/14740338.3.3.221

1 reference

10 August 2017

1 reference